Similar ACL revision rates between hamstring tendon and bone-patellar tendon-bone autografts in young males: study
Firathan Koca et al conducted a study to compare 5-year revision rates and patient-reported knee function after primary anterior cruciate ligament reconstruction (ACLR) using hamstring tendon (HT) versus bone-patellar tendon-bone (BPTB) autografts in a national registry-based cohort of young male patients aged 16–25 years.
Data were retrieved from the Swedish Knee Ligament Registry. Male patients aged 16–25 years undergoing primary ACLR with either HT or BPTB autografts between 2005 and 2018 were included. Patient-reported knee function was evaluated using the Knee injury and Osteoarthritis Outcome Score (KOOS), and the composite KOOS4 (pain, symptoms, sport and recreation, and quality of life [QoL]). Patient acceptable symptom state (PASS) and treatment failure (TF) thresholds were defined based on previously published thresholds for the KOOS4. Patients who underwent revision ACLR within 5 years of primary ACLR were identified. Between-group differences in KOOS outcomes were analyzed using analysis of covariance, while Cox proportional hazards regression analysis was applied to assess the 5-year risk of revision.
The key findings of the study were:
• Overall, 10,038 patients were included (HT: n = 9440 [94.0%]; BPTB: n = 598 [6.0%]).
• The sport and recreation subscale was higher in the HT group at both 1-year (68.5 ± 25.6 vs. 64.1 ± 26.5; p = 0.009) and 2- years (67.1 ± 26.9 vs. 59.9 ± 29.7; p < 0.001) follow-up.
• At the 2-year follow-up, patients in the HT group reported higher QoL scores (58.9 ± 25.1 vs. 55.2 ± 25.9; p = 0.038) and KOOS4 scores (71.7 ± 19.5 vs. 68.2 ± 20.7; p = 0.007).
• No significant differences were observed between the graft groups in the proportion of patients achieving a PASS based on the KOOS4 at the 1-, 2-, or 5-year follow-up.
• However, the proportion of patients classified as TF was lower in the HT group at the 2-year follow-up (9.8% vs. 14.0%; p = 0.039).
• The 5- year revision rate following ACLR was 7.3% in the HT group and 5.4% in the BPTB group.
• The hazard of revision ACLR was not significantly different between the graft groups (hazard ratio [HR]: 1.39, 95% confidence interval [CI]: 0.98–1.99; p = 0.064.).
The authors concluded – “No statistically significant differences in revision rates following primary ACLR were observed between HT and BPTB autografts in young males, although a trend toward a higher revision risk was observed in the HT group. HT autografts were associated with improved patient-reported knee function in the early follow up; however, these differences were not sustained at 5 years, suggesting similar long-term patient-reported knee function between graft types.”
Level of evidence: III.
For further details on the article refer to:
Analysis of the Swedish knee ligament registry shows similar anterior cruciate ligament revision rates between hamstring tendon and bone-patellar tendon-bone autografts in young males Firathan Koca et al Journal of ISAKOS 20 (2026) 101201 http://dx.doi.org/10.2106/JBJS.OA.25.00162
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.